Your browser doesn't support javascript.
loading
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
Moreno-Aspitia, Alvaro; Holmes, Eileen M; Jackisch, Christian; de Azambuja, Evandro; Boyle, Frances; Hillman, David W; Korde, Larissa; Fumagalli, Debora; Izquierdo, Miguel A; McCullough, Ann E; Wolff, Antonio C; Pritchard, Kathleen I; Untch, Michael; Guillaume, Sébastien; Ewer, Michael S; Shao, Zhimin; Sim, Sung Hoon; Aziz, Zeba; Demetriou, Georgia; Mehta, Ajay O; Andersson, Michael; Toi, Masakazu; Lang, Istvan; Xu, Binghe; Smith, Ian E; Barrios, Carlos H; Baselga, Jose; Gelber, Richard D; Piccart-Gebhart, Martine.
Afiliação
  • Moreno-Aspitia A; Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL, USA. Electronic address: morenoaspitia.alvaro@mayo.edu.
  • Holmes EM; Dundee Epidemiology and Statistics Unit, University of Dundee, Dundee, UK.
  • Jackisch C; Department of Gynecology and Obstetrics, Sana Klinikum Offenbach GmbH, Offenbach am Main, Germany.
  • de Azambuja E; Institute Jules Bordet and l' Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
  • Boyle F; Patricia Ritchie Centre for Cancer Care and Research, University of Sydney, Sydney, Australia.
  • Hillman DW; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Korde L; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Fumagalli D; Breast International Group, Brussels, Belgium.
  • Izquierdo MA; Novartis Pharma AG, Basel, Switzerland.
  • McCullough AE; Division of Anatomic Pathology, Mayo Clinic, Scottsdale, AZ, USA.
  • Wolff AC; Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA.
  • Pritchard KI; Canadian Cancer Trials Group (CCTG), Kingston, Ontario, Canada.
  • Untch M; Helios Klinikum Berlin-Buch, Berlin, Germany.
  • Guillaume S; Institute Jules Bordet and l' Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
  • Ewer MS; MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
  • Shao Z; Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Sim SH; Center for Breast Cancer, National Cancer Centre, Gyeonggi-do, South Korea.
  • Aziz Z; Allama Iqbal Medical College, Lahore, Pakistan.
  • Demetriou G; University of the Witwatersrand, Johannesburg, South Africa.
  • Mehta AO; Central India Cancer Research Institute, Nagpur, Maharashtra, India.
  • Andersson M; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
  • Toi M; Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Lang I; National Institute of Oncology, Budapest, Hungary.
  • Xu B; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People's Republic of China.
  • Smith IE; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Barrios CH; Latin American Cooperative Oncology Group (LACOG), Oncoclínicas, Porto Alegre, Brazil.
  • Baselga J; Oncology Research and Development, Astra-Zeneca, Cambridge, UK.
  • Gelber RD; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science Technology Research Foundation, Boston, MA, USA.
  • Piccart-Gebhart M; Institute Jules Bordet and l' Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
Eur J Cancer ; 148: 287-296, 2021 05.
Article em En | MEDLINE | ID: mdl-33765513

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article